BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32441647)

  • 21. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
    J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA Vasculitis in Adults: a Rare yet Challenging Disease.
    Yaseen K; Herlitz LC; Villa-Forte A
    Curr Rheumatol Rep; 2021 Jul; 23(7):50. PubMed ID: 34196893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is adiponectin in children with immunoglobulin A vasculitis a suitable biomarker of nephritis in the course of the disease?
    Dyga K; Machura E; Świętochowska E; Ziora K; Szczepańska M
    Endokrynol Pol; 2020; 71(6):512-517. PubMed ID: 32944925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
    Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
    Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study.
    Liao CH; Tsai M; Yang YH; Chiang BL; Wang LC
    Pediatr Rheumatol Online J; 2020 Nov; 18(1):86. PubMed ID: 33172497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.
    Hogan J; Godron A; Baudouin V; Kwon T; Harambat J; Deschênes G; Niel O
    Pediatr Nephrol; 2018 Jan; 33(1):111-116. PubMed ID: 28780657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgA vasculitis with nephritis in children.
    Dyga K; Szczepańska M
    Adv Clin Exp Med; 2020 Apr; 29(4):513-519. PubMed ID: 32356414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Nonimmune Factors on Renal Prognosis in Adult IgA Vasculitis With Nephritis: A Long-Term Retrospective Cohort Study.
    Guan Y; Liu S; Hao CM; Lai L
    J Rheumatol; 2023 Aug; 50(8):1032-1038. PubMed ID: 37127322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
    Geetha D; Specks U; Stone JH; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Fessler BJ; Ding L; Tchao NK; Ikle D; Jepson B; Brunetta P; Fervenza FC;
    J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adding Methylprednisolone and Cyclophosphamide Pulse Therapy Provides No Benefit in Pediatric IgAV Nephritis Grade III.
    Zhu Y; Dong Y; Li Y; Jin J; Ma Y
    Clin Pediatr (Phila); 2023 Jun; 62(6):615-621. PubMed ID: 36475327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
    Ozen S; Marks SD; Brogan P; Groot N; de Graeff N; Avcin T; Bader-Meunier B; Dolezalova P; Feldman BM; Kone-Paut I; Lahdenne P; McCann L; Pilkington C; Ravelli A; van Royen A; Uziel Y; Vastert B; Wulffraat N; Kamphuis S; Beresford MW
    Rheumatology (Oxford); 2019 Sep; 58(9):1607-1616. PubMed ID: 30879080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult onset of Immunoglobulin A vasculitis - A case report.
    Yagi S; Endo I; Murakami T; Hida T; Yamamoto Y; Soga T; Ise T; Kusunose K; Yamaguchi K; Fukuda D; Yamada H; Soeki T; Wakatsuki T; Kawahito S; Sata M
    J Med Invest; 2019; 66(3.4):344-346. PubMed ID: 31656302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgA vasculitis (Henoch-Schönlein purpura): refractory and relapsing disease course in the adult population.
    Van de Perre E; Jones RB; Jayne DRW
    Clin Kidney J; 2021 Aug; 14(8):1953-1960. PubMed ID: 34345419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of progressive Henoch-Schönlein purpura nephritis with tonsillectomy and steroid pulse therapy.
    Sugiyama H; Watanabe N; Onoda T; Kikumoto Y; Yamamoto M; Maeta M; Ohara N; Maeshima Y; Yamasaki Y; Makino H
    Intern Med; 2005 Jun; 44(6):611-5. PubMed ID: 16020890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.
    Ren P; Han F; Chen L; Xu Y; Wang Y; Chen J
    Am J Nephrol; 2012; 36(3):271-7. PubMed ID: 22965140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura).
    Heineke MH; Ballering AV; Jamin A; Ben Mkaddem S; Monteiro RC; Van Egmond M
    Autoimmun Rev; 2017 Dec; 16(12):1246-1253. PubMed ID: 29037908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study.
    Calvo-Río V; Loricera J; Martín L; Ortiz-Sanjuán F; Alvarez L; González-Vela MC; González-Lamuño D; Mata C; Gortázar P; Rueda-Gotor J; Arias M; Peiró E; Martínez-Taboada VM; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S45-51. PubMed ID: 23663681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Rituximab as an Off-Label Medication in Glomerular Diseases: Clinical Perspective.
    AlSahow A; Al-Muhaiteeb A; Nawar H; AlHelal B; AlYousef A; Abdallah E; AbuShall A; Elmekawi S; Meshal B; AlQallaf A; AlRajab H
    Med Princ Pract; 2022; 31(2):133-141. PubMed ID: 35021170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complete remission of nephrotic syndrome with methylprednisolone pulses in an adult with Schönlein-Henoch purpura].
    Segura Torres P; Borrego Utiel FJ; Pérez Del Barrio P; Ruiz Avila I
    Nefrologia; 2007; 27(1):96-8. PubMed ID: 17402892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring.
    Hackl A; Becker JU; Körner LM; Ehren R; Habbig S; Nüsken E; Nüsken KD; Ebner K; Liebau MC; Müller C; Pohl M; Weber LT
    Pediatr Nephrol; 2018 Apr; 33(4):619-629. PubMed ID: 29177628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.